Loading clinical trials...
Loading clinical trials...
The hyper IgD syndrome (HIDS) is an inflammatory disease caused by mevalonate kinase deficiency. There is no cure, and available treatments of HIDS febrile episodes have shown limited clinical efficac...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Michigan Technological University
NCT06838143 · Hereditary Periodic Fever Syndromes, Cryopyrin-associated Periodic Syndromes (CAPS), and more
NCT00260299 · Mevalonic Aciduria, Mevalonate Kinase Deficiency, and more
Michigan Techinical University
Houghton, Michigan
University of Nebraska Medical Center
Omaha, Nebraska
Oregon Health & Science University
Portland, Oregon
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions